88 related articles for article (PubMed ID: 19086854)
1. Would you prefer multiple reaction monitoring or antibodies with your biomarker validation?
Issaq HJ; Veenstra TD
Expert Rev Proteomics; 2008 Dec; 5(6):761-3. PubMed ID: 19086854
[No Abstract] [Full Text] [Related]
2. A 200-antibody microarray biochip for environmental monitoring: searching for universal microbial biomarkers through immunoprofiling.
Rivas LA; García-Villadangos M; Moreno-Paz M; Cruz-Gil P; Gómez-Elvira J; Parro V
Anal Chem; 2008 Nov; 80(21):7970-9. PubMed ID: 18837515
[TBL] [Abstract][Full Text] [Related]
3. [Palmitoleic acid].
Yamamoto Y; Fujisawa A; Yamashita S; Nagata Y
Nihon Rinsho; 1999 Dec; 57 Suppl():776-8. PubMed ID: 10778238
[No Abstract] [Full Text] [Related]
4. [Palmitoleic acid and oleic acid].
Yamamoto Y
Nihon Rinsho; 2010 Jul; 68 Suppl 7():849-52. PubMed ID: 20960883
[No Abstract] [Full Text] [Related]
5. Biomarker assay development and validation for large molecules in bioanalysis: what are the challenges and how are they overcome?
Stevenson LF
Bioanalysis; 2012 Nov; 4(22):2657-9. PubMed ID: 23210647
[No Abstract] [Full Text] [Related]
6. Potential biomarkers for the diagnosis of stroke.
Jensen MB; Chacon MR; Sattin JA; Levine RL; Vemuganti R
Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):389-93. PubMed ID: 19379063
[TBL] [Abstract][Full Text] [Related]
7. Verification and validation: whose responsibility, manufacturer or end user?
Hill R
Ann Clin Biochem; 2011 Mar; 48(Pt 2):93-4. PubMed ID: 21406560
[No Abstract] [Full Text] [Related]
8. Proposal for levels of evidence schema for validation of a soluble biomarker reflecting damage endpoints in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, and recommendations for study design.
Maksymowych WP; Fitzgerald O; Wells GA; Gladman DD; Landewé R; Ostergaard M; Taylor WJ; Christensen R; Tak PP; Boers M; Syversen SW; Bathon JM; Ritchlin CJ; Mease PJ; Bykerk VP; Garnero P; Geusens P; El-Gabalawy H; Aletaha D; Inman RD; Kraus VB; Kvien TK; van der Heijde D
J Rheumatol; 2009 Aug; 36(8):1792-9. PubMed ID: 19671814
[TBL] [Abstract][Full Text] [Related]
9. Biomarker validation: movement towards personalized medicine.
Zhang X
Expert Rev Mol Diagn; 2007 Sep; 7(5):469-71. PubMed ID: 17892353
[No Abstract] [Full Text] [Related]
10. [State of the art and method validations: application to fidelity performance].
Scherrer F; Boisson RC; Eynard JC; Chamard D; Poggi B; Grafmeyer D
Ann Biol Clin (Paris); 2008; 66(6):721-5. PubMed ID: 19091667
[TBL] [Abstract][Full Text] [Related]
11. Multiplex immunoassays: an invaluable tool for biomarker discovery and validation.
Lehr S
Arch Physiol Biochem; 2012 Oct; 118(4):191. PubMed ID: 22747464
[No Abstract] [Full Text] [Related]
12. A proposal for validation of antibodies.
Uhlen M; Bandrowski A; Carr S; Edwards A; Ellenberg J; Lundberg E; Rimm DL; Rodriguez H; Hiltke T; Snyder M; Yamamoto T
Nat Methods; 2016 Oct; 13(10):823-7. PubMed ID: 27595404
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers of sepsis.
Marshall JC; Reinhart K;
Crit Care Med; 2009 Jul; 37(7):2290-8. PubMed ID: 19487943
[TBL] [Abstract][Full Text] [Related]
14. 'How did you validate ...?' A plea for validation studies.
Rebulla P
Transfus Med; 2009 Feb; 19(1):1. PubMed ID: 19302448
[No Abstract] [Full Text] [Related]
15. One step at a time: identification and validation of biomarkers for nonalcoholic steatohepatitis.
Talwalkar JA
Hepatology; 2009 Oct; 50(4):1000-3. PubMed ID: 19787817
[No Abstract] [Full Text] [Related]
16. Correlation between clinical activity and serological markers in a wide cohort of patients with systemic lupus erythematosus: an eight-year prospective study.
Villegas-Zambrano N; Martínez-Taboada VM; Bolívar A; San Martín M; Alvarez L; Marín MJ; López-Hoyos M
Ann N Y Acad Sci; 2009 Sep; 1173():60-6. PubMed ID: 19758133
[TBL] [Abstract][Full Text] [Related]
17. When antibodies mislead: the quest for validation.
Baker M
Nature; 2020 Sep; 585(7824):313-314. PubMed ID: 32895531
[No Abstract] [Full Text] [Related]
18. Study on homogeneous competitive immune reaction by fluorescence correlation spectroscopy: using synthetic peptide as antigen.
Xie C; Dong C; Ren J
Talanta; 2009 Aug; 79(3):971-4. PubMed ID: 19576474
[TBL] [Abstract][Full Text] [Related]
19. Validation of a fast liquid chromatography-UV method for the analysis of drugs used in combined cardiovascular therapy in human plasma.
Iriarte G; Gonzalez O; Ferreirós N; Maguregui MI; Alonso RM; Jiménez RM
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3045-53. PubMed ID: 19660995
[TBL] [Abstract][Full Text] [Related]
20. Internal and external validity: can you apply research study results to your patients?
Patino CM; Ferreira JC
J Bras Pneumol; 2018; 44(3):183. PubMed ID: 30043882
[No Abstract] [Full Text] [Related]
[Next] [New Search]
